CLS 422 Clinical Immunohematology I Take Home Quiz Day Two ...
CLS 422 Clinical Immunohematology I Take Home Quiz Day Two ...
CLS 422 Clinical Immunohematology I Take Home Quiz Day Two ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
5. Which of the following antibodies typically shows enhanced reactivity with<br />
enzyme treated red blood cells?<br />
a. Anti-Fy a<br />
b. Anti-Jk a<br />
c. Anti-N<br />
d. Anti-s<br />
6. Which of the following could be classified as a low prevalence antigen?<br />
a. I<br />
b. Jk b<br />
c. K<br />
d. s<br />
7. An anti-Jk a that is showing dosage will react strongest with which of the<br />
following cells?<br />
a. Jk(a+b+)<br />
b. Jk(a+b-)<br />
c. Jk(a-b+)<br />
d. Jk(a-b-)<br />
8. The purpose of performing the antibody screen is to detect clinically significant<br />
______________:<br />
a. Alloantibodies<br />
b. Autoantibodies<br />
c. Expected ABO antibodies<br />
d. Heterophile antibodies<br />
9. Antibody screening cell sets are comprised of RBCs from which ABO group?<br />
a. A<br />
b. B<br />
c. O<br />
d. Any ABO group is acceptable<br />
10. What phases of testing must be included in the antibody screen?<br />
a. 37 o C & AHG<br />
b. Immediate spin, 37 o C & AHG<br />
c. Immediate spin, room temperature & check cells<br />
d. Tube, gel, solid phase<br />
<strong>CLS</strong> <strong>422</strong> <strong>Clinical</strong> <strong>Immunohematology</strong> I Page 2 of 6<br />
Student Lab <strong>Day</strong> <strong>Two</strong> <strong>Take</strong> <strong>Home</strong> <strong>Quiz</strong>
Change language